newsfilter
← Latest News
GlobeNewswire·

Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split

BOSTON, June 13, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients,